CIZ — Cizzle Biotechnology Holdings Share News
0.000.00%
Last trade - 00:00Brief: Cizzle Biotechnology and Cizzle Bio Achieve CLIA Validation
Cizzle Biotechnology - Update on Launch of Lung Cancer Test in USA
Cizzle Biotechnology - Interim Results
Cizzle Biotechnology - Laboratory Expansion to Accelerate Sales in USA
Cizzle Biotechnology - Update on Sales in USA
Cizzle Biotechnology - Half Year Operational Update
Cizzle Biotechnology - Notice of AGM
Cizzle Biotechnology - Issue of Options, Salary Waivers, Incentive Plan
Cizzle Biotechnology - Conversion of Convertible Loan Notes
Cizzle Biotechnology - Final results for the year ended 31 December 2025
Cizzle Biotechnology - £250,000 Funding Facility
Cizzle Biotechnology - Progress on Launch of Biomarker Test in USA
Brief: Cizzle Biotechnology Holdings Grants Canadian Patent For CIZ1B Biomarker
Brief: Cizzle Biotechnology Announces LOI With Leading UK Clinical Diagnostic Group
Cizzle Biotechnology - £250,000 Convertible Loan Note Issue
Cizzle Biotechnology - LOI with leading UK Clinical Diagnostic Group
Cizzle Biotechnology - Interim Results
Brief: Cizzle Biotechnology Says Cizzle Bio Inc Is Completing Validation Of CIZ1B Test With Omni Health
Cizzle Biotechnology - Update on Clinical Laboratory Partnerships in USA